HomeKNE • CVE
add
Kane Biotech Inc
Nakaraang pagsara
$0.11
Sakop ng araw
$0.11 - $0.11
Sakop ng taon
$0.075 - $0.17
Market cap
13.84M CAD
Average na Volume
98.76K
P/E ratio
2.37
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.28M | 4,650.21% |
Gastos sa pagpapatakbo | 1.17M | 17.62% |
Net na kita | -605.81K | 56.05% |
Net profit margin | -47.23 | 99.07% |
Kita sa bawat share | — | — |
EBITDA | -564.91K | 38.02% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 544.38K | -66.46% |
Kabuuang asset | 3.91M | -35.03% |
Kabuuang sagutin | 4.59M | -64.73% |
Kabuuang equity | -688.65K | — |
Natitirang share | 137.51M | — |
Presyo para makapag-book | -11.00 | — |
Return on assets | -38.31% | — |
Return on capital | -93.34% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -605.81K | 56.05% |
Cash mula sa mga operasyon | -538.12K | 24.77% |
Cash mula sa pag-invest | -8.46K | 74.20% |
Cash mula sa financing | 81.03K | -93.39% |
Net change in cash | -465.55K | -197.59% |
Malayang cash flow | -676.93K | -100.55% |
Tungkol
Itinatag
2001
Headquarters
Website
